IVIG治疗对实验诱导的骨质疏松症的有益影响

Savaş Özdemir1, Oytun Erbas2

  • 1Department of Gynecology and Obstetrics, Istanbul Prof. Dr. Cemil Taşçıoğlu City Hospital, Istanbul, Turkey.

Cirugia y cirujanos
|March 19, 2024
PubMed
概括

静脉注射免疫球蛋白 (IVIG) 通过减少炎症和调节RANKL-β-catenin通路来改善骨质疏松症模型中的骨密度和结构. 这表明IVIG是骨质疏松症的潜在治疗方法.